Display options
Share it on

Pediatr Rheumatol Online J. 2012 Jun 22;10(1):18. doi: 10.1186/1546-0096-10-18.

Prolidase deficiency associated with systemic lupus erythematosus (SLE): single site experience and literature review.

Pediatric rheumatology online journal

Yonatan Butbul Aviel, Hana Mandel, Emily Avitan Hersh, Reuven Bergman, Orly Eshach Adiv, Anthony Luder, Riva Brik

Affiliations

  1. Department of Pediatrics B, Haifa, Israel. [email protected].

PMID: 22726576 PMCID: PMC3623899 DOI: 10.1186/1546-0096-10-18

Abstract

INTRODUCTION: Prolidase deficiency (PD) is a rare autosomal recessive disorder which may have a wide spectrum of clinical features. These features include a characteristic facies, cognitive impairment, rashes or skin ulceration, splenomegaly, recurrent infections involving mainly the respiratory system, and iminodipeptiduria. The disorder is caused by a mutation in the PEPD gene.

OBJECTIVE: To describe a cohort of unrelated PD patients from Northern Israel whose inborn error of metabolism was associated with systemic lupus erythematosus (SLE) and to identify in the medical literature all PD cases mimicked by and/or associated with SLE.

METHODS: Three patients with PD associated with SLE were clinically, biochemically and genetically investigated. These patients were from 3 unrelated consanguineous families residing in Northern Israel. A computer-assisted (PubMed) search of the medical literature from 1975 to 2011 was performed using the following key words: Prolidase deficiency, SLE, and systemic lupus erythematosus.

RESULTS: An association between PD and SLE was found in 10 PD patients. These 10 patients included three from our cohort of 23 PD patients, and seven out of just under 70 PD patients previously reported in the literature.

CONCLUSION: The present findings underscore the relatively high incidence of the association between SLE and PD, suggesting that this association may not be coincidental. The phenotypic similarities between SLE and PD might suggest that the PEPD gene constitutes a modifier gene or a genetic risk factor in the causation of SLE.

References

  1. Hum Genet. 2002 Oct;111(4-5):314-22 - PubMed
  2. Arthritis Rheum. 1985 Jan;28(1):80-6 - PubMed
  3. Radiology. 1984 Aug;152(2):409-12 - PubMed
  4. Rheum Dis Clin North Am. 1988 Apr;14(1):15-23 - PubMed
  5. J Am Acad Dermatol. 2010 Jun;62(6):1031-4 - PubMed
  6. Eur J Pediatr. 2010 Jun;169(6):727-32 - PubMed
  7. J Inherit Metab Dis. 2007 Oct;30(5):814 - PubMed
  8. Arch Dermatol. 1987 Apr;123(4):493-9 - PubMed
  9. Nihon Naika Gakkai Zasshi. 2009 Jan 10;98(1):150-2 - PubMed
  10. J Am Acad Dermatol. 1993 Nov;29(5 Pt 2):818-21 - PubMed
  11. Lupus. 2008 Apr;17(4):314-22 - PubMed
  12. Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 5;153B(1):46-56 - PubMed
  13. Amino Acids. 2008 Nov;35(4):739-52 - PubMed
  14. Br J Dermatol. 2001 Mar;144(3):635-6 - PubMed
  15. Arch Dis Child. 1997 May;76(5):441-4 - PubMed
  16. J Hum Genet. 2004;49(9):500-506 - PubMed
  17. J Pediatr. 1986 Apr;108(4):576-9 - PubMed
  18. Virchows Arch A Pathol Anat Histopathol. 1985;406(1):125-31 - PubMed
  19. Semin Arthritis Rheum. 1990 Aug;20(1):48-56 - PubMed
  20. J Pediatr. 2008 Apr;152(4):550-6 - PubMed
  21. J Pediatr. 1978 Nov;93(5):810-2 - PubMed

Publication Types